AHN 150326_Catenion_8344

“Translating new technologies into viable business ideas”

Arno Heuermann COO, Partner, Managing Director
Christian Elze

“China’s policy makers are making a concerted long-term effort to build a competitive biomedical innovation system – but R&D-based value creation
is only just beginning.”

Christian Elze Senior Partner
Markus Thunecke

“Is biopharma ready to embrace the new biology?”

Dr. Markus Thunecke Senior Partner
Sophie von Dyrander

“My decision to join Catenion? Here I found what I was looking for – high level strategy work, international clients and the team spirit of a smaller firm.”

Graham Scholefield

“Sitting at the boundary between science and business is an incredibly rewarding experience”

COG 150326_Catenion_0233

“I help R&D teams deliver on the promise of gene therapy”

Matthias Krings

“Change-Management is a team effort – let’s get started”

Dr. Matthias Krings Senior Partner
DLI 150326_Catenion_8264

“We help our clients to achieve best practise in managing R&D performance”


Future-proofing old school pharma with new biology

DDW insights, November 2015 It is seems just about every week one of the major news and analysis publications such as The Economist, The New York Times, FORBES, TIME or some other major  ublication drills into the hotbutton issue of the perceived disparity between oncology drug pricing and medical-economic value. It is a situation that is undeniably acute considering the following; … published with kind [...]
Download this article

John Herrmann, Ph.D. has joined CATENION as an Expert Partner in Oncology

John Herrmann, Ph.D. has joined CATENION as an Expert Partner in Oncology. John’s main roles will be to help CATENION expand its US client base and to serve as the company’s Oncology strategy lead. “We are very happy that John is complementing our team, as this further strengthens our position as the premier management consulting [...]

Meet Us

Sep. 28–30, 2015

PSA: The Pharmaceutical Strategy Conference 2015, New York

Nov. 11 - 12, 2015

BBC NY/NJ CEO Conference, Boston

Nov. 5-9, 2015

AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, Boston

Nov. 2nd - 4th

Bio-Europe, Germany, Munich – booth:B1/6

November 11, 2015

Kyoto University, Lecture on „Healthcare Systems: Dynamics and Reform“ & Seminar on “ Development of a Global Clinical Trial Strategy for Lupus”

Nov. 19-21, 2015

Therapeutic Area Partnerships (TAP) – Boston

Jan. 25th-27th, 2016

Strategic Project & Portfolio Management for Pharma, Spain, Barcelona

Mar. 3rd & 4th, 2016

Pharma PPM Toolbox, Switzerland, Basel